Coronavirus: Nantes Biotech Valneva, in the Vaccine Race, Starts Testing on Humans
VACCINE: Based in Nantes, the Franco-Austrian company, Valneva hopes to market its coronavirus vaccine at the end of 2021 Valneva will start clinical trials in humans for its coronavirus vaccine candidate. The tests will be carried out in the United Kingdom, whose government has secured the supply of 60 million doses. The Franco-Austrian biotech Valneva, specializing in […]
Continue Reading